在纳米酶辅助CRISPR诊断技术的进步
Lang Luo1,2, Yeling Yang2, Yubei Zhang2
1Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, China.
Frontiers in bioengineering and biotechnology
|March 16, 2026
概括
纳米酶通过克服像低信号输出这样的局限性来增强集群定期间隔的短时间palindromic重复 (CRISPR) 诊断. 这种整合提供了改进的核酸检测和更广泛的诊断应用.
科学领域:
- 生物技术是生物技术.
- 纳米技术 纳米技术
- 分子诊断学 分子诊断学
背景情况:
- 集群定期间隔的简短平行体重复 (CRISPR) 系统为诊断提供精确的核酸识别.
- 传统的CRISPR诊断面临挑战,包括低信号输出,依赖外部酶和高设备成本.
研究的目的:
- 综合评估纳米酶增强CRISPR诊断技术的进展.
- 探索纳米酶与CRISPR/Cas系统的整合,以提高诊断能力.
主要方法:
- 审查了CRISPR诊断和纳米酶的基本属性.
- 分析了CRISPR/Cas系统和纳米酶之间的合机制.
- 评估了用于检测核酸和非核酸目标的应用.
主要成果:
- 纳米酶通过提供酶模拟催化活性来解决传统CRISPR诊断的局限性.
- 集成增强了CRISPR信号放大,并允许通过Cas蛋白功能进行调节.
- 证明了用于检测核酸和非核酸目标的应用.
结论:
- 纳米酶增强的CRISPR技术为先进的生物诊断提供了一个有前途的方法.
- 未来的方向包括同质系统,集成设备和单原子纳米酶,以进一步改进.
更多相关视频
07:59Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
1.5K
08:25Using a Fluorescent PCR-capillary Gel Electrophoresis Technique to Genotype CRISPR/Cas9-mediated Knockout Mutants in a High-throughput Format
Published on: April 8, 2017
14.5K
相关概念视频
CRISPR
58.8K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
58.8K
CRISPR
18.8K
18.8K
CRISPR/Cas9 Genome Editing
2.5K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
2.5K
CRISPR and crRNAs
19.5K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
19.5K
